ARCHIVES

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

NCCS Urges FDA To Finalize Regulations On Expanded Access.

December 19, 2008

In Brief: James Wallace Named CALGB Executive Officer; Gritz Receives First Joseph Cullen Award

September 11, 1992

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

Medenica Granted Extension Of Privileges At Hilton Head Hospital

November 26, 1993

Three cancer centers joined the Multiple Myeloma Research Consortium.

September 16, 2005